Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.02 +0.25 (+13.84%)
At close: Oct 20, 2026 · 4:00 PM EDT

Acumen Pharmaceuticals (ABOS) Operating Leases (2022 - 2024)

Updated

Acumen Pharmaceuticals' Operating Leases came in at $185,000 for Q3 2024, down 15.5% from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Operating Leases (2022 - 2024) Analysis & Trends

At the end of FY2023, Acumen Pharmaceuticals' Operating Leases was $284,000.

  • The Q3 2024 figure represents the lowest quarterly Operating Leases since Q2 2022.
  • Business Quant data shows ABOS's Operating Leases at $219,000 (Q2 2024), $252,000 (Q1 2024) and $284,000 (Q4 2023) in the three quarters before Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Acumen Pharmaceuticals 147.03 Mn -335.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 185,000.00
Jun 30, 2024 219,000.00
Mar 31, 2024 252,000.00
Dec 31, 2023 284,000.00
Jun 30, 2022 25,000.00
Mar 31, 2022 62,000.00
API Access

Acumen Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ABOS&period=max&api_key=YOUR_API_KEY